跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUBOXONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUBOXONE
Authorized
STANDARD
SUBOXONE
INDIVIOR UK LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
149644a26daa4412
Company
INDIVIOR UK LIMITED
Type
Standard
Approval Details
Approval Id
149644a26daa4412
Drug Approval Canada Name
SUBOXONE
Product Name
SUBOXONE
Status
Marketed
Status Date
2016-04-01
Original Market Date
2007-11-26
Din
02295709
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Sublingual
Schedule
Narcotic (CDSA I)
Ahfs
28:08.12
Atc Original
N07BC51 BUPRENORPHINE, COMBINATIONS
Atc Name
n 07 bc 51
Aig Number
0252216002
Company Name
INDIVIOR UK LIMITED
Company Address
The Chapleo Building, Henry Boot Way, Hull, --, United Kingdom, HU4 7DY
Company Detail Path
/organization/indivior-uk-limited
Company Information
Pharmaceutical Company Name
INDIVIOR UK LIMITED
Country Name
United Kingdom
City Name
slough,country_gb
Address
234 Bath Road
Active Ingredients
NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)
2 MG
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)
8 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
149644a26daa4412
Type
Standard
Back to Health Canada Approvals